Direxion Daily TSLA Bull 2X Shares, Neogen, Carter’s, Brown-Forman, Allurion Technologies, TransCode Therapeutics, and AltC Acquisition are the seven Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small cap stocks are shares of companies with relatively small market capitalizations, typically ranging from $300 million to $2 billion. They often represent emerging businesses with significant growth potential yet may come with higher volatility and risk compared to larger, more established companies. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.
Direxion Daily TSLA Bull 2X Shares (TSLL)
Read Our Latest Research Report on TSLL
Neogen (NEOG)
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Shares of Neogen stock traded down $0.12 during trading on Friday, reaching $8.85. The company’s stock had a trading volume of 36,396,580 shares, compared to its average volume of 2,130,246. The company has a 50-day simple moving average of $10.46 and a two-hundred day simple moving average of $12.98. Neogen has a 1-year low of $8.60 and a 1-year high of $18.58. The company has a quick ratio of 2.46, a current ratio of 3.77 and a debt-to-equity ratio of 0.33. The company has a market cap of $1.92 billion, a price-to-earnings ratio of -4.04 and a beta of 1.27.
Read Our Latest Research Report on NEOG
Carter’s (CRI)
Carter’s, Inc. engages in the business of brand marketing of young children’s apparel. It operates through the following segments: the United States (US) Retail, US Wholesale, and International. The US Retail segment includes selling products through retail stores and ecommerce websites. The US Wholesale segment focuses on wholesale partners.
CRI traded down $0.04 on Friday, reaching $40.81. 7,530,286 shares of the stock were exchanged, compared to its average volume of 1,105,316. The company’s 50-day moving average price is $48.50 and its 200 day moving average price is $55.39. Carter’s has a fifty-two week low of $38.84 and a fifty-two week high of $86.24. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.21 and a quick ratio of 0.96. The firm has a market capitalization of $1.47 billion, a PE ratio of 6.48, a PEG ratio of 3.37 and a beta of 1.24.
Read Our Latest Research Report on CRI
Brown-Forman (BF-B)
Brown-Forman Corporation, together with its subsidiaries, manufactures, distills, bottles, imports, exports, markets, and sells various alcoholic beverages. It provides wines, whiskey spirits, whiskey-based flavored liqueurs, ready-to-drink and ready-to-pour products, vodkas, tequilas, gin, brandy, rum, bourbons, and liqueurs.
BF-B traded down $0.27 on Friday, reaching $34.65. 8,046,096 shares of the stock were exchanged. The firm’s fifty day moving average is $33.36 and its 200-day moving average is $40.24.
Read Our Latest Research Report on BF-B
Allurion Technologies (ALUR)
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
ALUR traded up $1.32 on Friday, reaching $3.60. 74,301,375 shares of the stock were exchanged, compared to its average volume of 706,727. The company’s 50-day moving average price is $4.00 and its 200 day moving average price is $10.14. Allurion Technologies has a fifty-two week low of $2.15 and a fifty-two week high of $98.75. The firm has a market capitalization of $17.24 million, a PE ratio of -0.30 and a beta of -0.59.
Read Our Latest Research Report on ALUR
TransCode Therapeutics (RNAZ)
TransCode Therapeutics, Inc., a ribonucleic acid (RNA) oncology company, focuses on the development and commercialization of drugs and diagnostics for treating and identifying various cancers. Its lead therapeutic candidate is TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in a range of cancers, including breast, pancreatic, ovarian, colon cancer, glioblastomas, and others.
RNAZ traded up $0.35 on Friday, reaching $1.12. 215,588,298 shares of the stock were exchanged, compared to its average volume of 1,521,393. The company’s 50-day moving average price is $5.28 and its 200 day moving average price is $227.13. TransCode Therapeutics has a fifty-two week low of $0.65 and a fifty-two week high of $66.33.
Read Our Latest Research Report on RNAZ
AltC Acquisition (ALCC)
AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.
ALCC traded down $0.61 on Friday, reaching $27.16. 8,093,336 shares of the stock were exchanged, compared to its average volume of 723,393. The company’s 50-day moving average price is $35.80 and its 200 day moving average price is $23.65. AltC Acquisition has a fifty-two week low of $10.27 and a fifty-two week high of $18.80.
Read Our Latest Research Report on ALCC
See Also
- MarketBeat’s Top Five Stocks to Own in March 2025
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Affirm Stock: Should You Buy the Dip After Walmart Setback?